) and quality (data not shown) ratings after undecanal exposure were then compared to the initial ratings (for the BBB control group responses to the first and the last stimulus were compared). Subjects of the BBB group reported consistent intensities for the three trials (105.1 ± 6.2 %), indicating no sign of adaptation. In contrast, the experimental group (BUB) showed a significant decrease in bourgeonal intensity after brief exposure to undecanal (35.8 ± 2.6%). Such an undecanal dependent effect was not reported by subjects rating the intensity of helional (91.3 ± 9.5%), an odorant structurally related to bourgeonal, geraniol (87.7 ± 7.2%), octanal (104.3 ± 13.9%), isoamyl acetate (99.4 ± 10.1%), vanillin (80.4 ± 24.9%), or eucalyptol (82.2 ± 10.1%). In all groups, no sex-related differences were observed and hedonic ratings changed only slightly after In summary, we demonstrate expression of hOR17-4 in the human olfactory epithelium and hypothesize a basically identical receptor operation in both olfactory tissue and spermatozoa. The present study indicates a predominant or even exclusive role of hOR17-4 in olfactory bourgeonal detection or it suggests the inhibition of more bourgeonalactivated human ORs by undecanal. However, undecanal does not affect certain other ORs sensitive to a broad range of odorants (control groups), and a general inhibitory mechanism aside from the receptor level can thus be excluded as well. It seems likely that the antagonistic property of a particular (structurally unrelated) odorant pair represents a common principle of OR activation/inactivation. Thus, design of (odorless) antagonists that specifically target ORs sensitive to unpleasant odors seems feasible in the future.
Nasal expression of the 'sperm' olfactory receptor hOR17-4 was demonstrated by RT-PCR on human olfactory mucosa cDNA ( Figure 1 ). We identified and mapped distinct exons located upstream of the coding sequence (Fig. 1C) initially postulated by means of bioinformatic analyses. Such upstream exons have been described for a number of human and murine olfactory receptor genes [4] . RT-PCR analysis based on intron-spanning primers proves expression of hOR17-4 in human olfactory epithelium. PCR-products amplified from potential contaminating traces of genomic DNA can be distinguished by size.
In sperm, the most potent hOR17-4 agonist is the odorant bourgeonal, whereas the receptor is antagonized by undecanal [3] . Therefore, we investigated olfactory perception of bourgeonal after brief undecanal exposure. 488 subjects (male and female, 21-37 years of age) were separated into one experimental group, sniffing bourgeonal-undecanal-bourgeonal (BUB) in succession, and various control groups (sniffing either bourgeonal three times (BBB) or a control odorant X-undecanal-odorant X (XUX) in succession). Odorants were presented for five seconds with brief interstimulus intervals (ISI) of 2 s and intensities as well as hedonics were obtained as previously described [5] . Intensity ( Figure 1D ) and quality (data not shown) ratings after undecanal exposure were then compared to the initial ratings (for the BBB control group responses to the first and the last stimulus were compared). Subjects of the BBB group reported consistent intensities for the three trials (105.1 ± 6.2 %), indicating no sign of adaptation. In contrast, the experimental group (BUB) showed a significant decrease in bourgeonal intensity after brief exposure to undecanal (35.8 ± 2.6%). Such an undecanal dependent effect was not reported by subjects rating the intensity of helional (91.3 ± 9.5%), an odorant structurally related to bourgeonal, geraniol (87.7 ± 7.2%), octanal (104.3 ± 13.9%), isoamyl acetate (99.4 ± 10.1%), vanillin (80.4 ± 24.9%), or eucalyptol (82.2 ± 10.1%). In all groups, no sex-related differences were observed and hedonic ratings changed only slightly after In summary, we demonstrate expression of hOR17-4 in the human olfactory epithelium and hypothesize a basically identical receptor operation in both olfactory tissue and spermatozoa. The present study indicates a predominant or even exclusive role of hOR17-4 in olfactory bourgeonal detection or it suggests the inhibition of more bourgeonalactivated human ORs by undecanal. However, undecanal does not affect certain other ORs sensitive to a broad range of odorants (control groups), and a general inhibitory mechanism aside from the receptor level can thus be excluded as well. It seems likely that the antagonistic property of a particular (structurally unrelated) odorant pair represents a common principle of OR activation/inactivation. Thus, design of (odorless) antagonists that specifically target ORs sensitive to unpleasant odors seems feasible in the future. 
